Brady Corporation delivered a solid QQ3 2024 performance characterized by sustainable top-line growth, expanding margins, and strong cash generation. Organic sales rose 4.5% driven by both Americas/Asia (4.5%) and Europe/Australia (4.4%), underscoring Brady’s ability to capture wallet share across regions despite a sluggish macro environment. Total revenue grew 1.9% for the quarter after accounting for divestitures (-2.3%) and foreign currency headwinds (-0.3%), reflecting a disciplined portfolio management stance. The quarter produced a company-record GAAP EPS of $1.05 and Non-GAAP EPS of $1.09, up 9.4% and 14.7% year over year, respectively, supported by an improved gross margin of 51.6% (up 130 basis points YoY). Management highlighted ongoing investments in R&D, sales capacity, and a prudent capital allocation framework that includes dividends, opportunistic buybacks, and selective M&A. Brady also announced the launch of three new products this quarter and signalled the Gravotech acquisition as a strategic fit to broaden the company’s identification ecosystem, including direct part marking capabilities. Looking ahead, Brady raised its fiscal 2024 EPS guidance to a GAAP range of $3.93-$4.00 and a non-GAAP range of $4.08-$4.15, while maintaining a low single-digit organic sales growth outlook. Management cautioned that the trajectory remains sensitive to USD strength, inflation, and macro activity, but reiterated a commitment to deploying capital to drive long-term shareholder value.